SMART@Home Feasibility Trial for Asthma in Teens

This study is testing a digital tool called SMART@Home to help teenagers aged 12-18 with asthma manage their condition better. The SMART@Home tool will send daily reminders for medication and diary entries, and provide educational content about managing asthma. The researchers want to see if using SMART@Home helps teens stick to their medication schedule and how often they use the app over 6 months. You might be able to join if you have asthma, are between 12 and 18 years old, and you and your caregiver speak English. The study is currently unclear about its recruitment status and plans to enroll 25 participants.

Study design
This is an interventional study planning to enroll 25 participants. It is not specified if it is randomized or blinded.
What's involved
Participants will receive daily medication and diary completion reminders through the SMART@Home tool. They will also receive additional educational content regarding self-management skills.
Compensation
Not stated in the trial record.
Follow-up
Medication adherence and app usage will be measured at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06159127

SMART@Home Feasibility Trial

Recruiting
NAAges 12–18InterventionalTreatment
Children's Hospital Medical Center, Cincinnati
~25 participants
Updated 2026-07-02 on ClinicalTrials.gov
What's tested:SMART@Home

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Medication Adherence
Measured over 6 months
+1 more outcome measured
Asthma
Asthma in Children
1 sites across 1 states
Ohio1
  • Kevin Hommel, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital Medical Center, Cincinnati
  • Rachelle Ramsey, PhD · STUDY_CHAIR · Children's Hospital Medical Center, Cincinnati
  • Matt Wortman, PhD · STUDY_CHAIR · Children's Hospital Medical Center, Cincinnati

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients diagnosed with a chronic medical condition requiring regular treatment, i.e., asthma
Ages 12-18
English fluency for patient and caregiver

Exclusion

Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review
Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review
  • Medication Adherence6 months

    Monthly adherence will be calculated by comparing doses taken to doses recommended by IMAAP. Participants will also report rescue medication use each month when completing the ACT.

  • Number of days app used6 months

    Number of diaries completed by participant